Blog Topics
IV Therapy in Japan: Stem Cell Protocols, Costs, and Safety
Through advanced IV therapy, Blu CLINIC (Osaka & Ginza, Tokyo) believes that cell-level care is the foundation of personal well-being. Under Dr. Saori Shimada’s clinical approach, the focus remains firmly on biological evidence rather than fleeting trends. No simple miracles. Just calculated, documented science. Clients crossing oceans to arrive at our private clinics seek clarity, not marketing noise. This guide examines the mechanism, safety profile, and regulatory reality of cellular administrations in Japan.
Understanding IV Therapy in Modern Regenerative Medicine
A treatment focused on biological delivery systems—not simply hydration or aesthetic IV therapy. We must first strip away the hyperbole surrounding intravenous treatments. In our clinical context, an IV drip is not a casual vitamin boost. It is a precise biological tool. Intended to support the body’s intrinsic repair mechanisms through systemic cellular administration.
The Role of Intravenous Drips in Systemic Cellular Delivery
When discussing IV therapy within regenerative protocols, the objective is to introduce cultured cells directly into the bloodstream. This method allows the biological material to circulate systemically, rather than being confined to a single localized area. The physiological response varies significantly from client to client.
The Biological Mechanism of Intravenous Cellular Administration
To be precise, the primary component of our intravenous protocol is the client’s own tissue. Autologous application. Strict processing.
How Autologous MSCs Navigate the Body via IV Therapy
Mesenchymal stem cells (MSCs) are multipotent cells capable of differentiating into various cell types under specific conditions. The procedure begins with the extraction of a small volume of abdominal fat. From this adipose tissue, MSCs are carefully isolated and cultivated in a dedicated cell processing center (CPC). Once administered intravenously, these cells circulate through the body and may help support tissue repair by releasing specific cytokines and growth factors.
Strict Regulatory Oversight: The Japanese Medical Framework
Strict oversight governs all cellular procedures here. The Japanese Ministry of Health, Labour and Welfare (MHLW) mandates specific protocols under the Act on the Safety of Regenerative Medicine (ASRM). Our facility operates strictly within this legal structure.
Treatments are notified to and filed with MHLW under the Act. Transparency is non-negotiable.
(Provision Plan Numbers)
Osaka Clinic: No. PB5260003 (Systemic/Pain) & No. PB5260002 (Fibroblast)
Ginza Clinic: No. PB3260095 (Systemic/Pain) & No. PB3260093 (Fibroblast)
The Clinical Timeline: Intravenous Administration at Blu CLINIC
With conveniently located clinics in both Osaka (a 3-minute walk from Osaka-Umeda Station) and Tokyo (walking distance from Higashi-Ginza / Ginza Stations), stepping into Blu CLINIC marks the beginning of a highly structured medical timeline. Discreet. Safe. Highly structured.
Preparation, Culture, and the IV Procedure
| Clinical Phase | Action Required | Location |
| Initial Assessment | Preliminary blood testing (included in package) / Blu CLINIC (upon arrival) | Blu CLINIC (Japan) |
| Tissue Collection | Extraction of abdominal fat | Blu CLINIC (Japan) |
| Cell Processing | 3–4 weeks of rigorous cultivation | Affiliated domestic CPC |
| IV Administration | Intravenous drip session | Blu CLINIC (Japan) |
Safety Protocols and Managing Associated Risks
Medical interventions carry inherent risks. Our priority is to ensure you are fully informed before making any decisions.
Addressing Transient Responses During and After the IV Drip
Clients may experience pain, swelling, redness, and bruising at the harvest site. Following the IV drip, transient fever and allergic reactions occasionally occur. In rare instances, infection or breathing difficulties could manifest. We continuously monitor vital signs during the administration phase and maintain strict emergency protocols.
Financial Considerations and Fee Structure for International clients
Cost transparency is a clinical obligation. All listed figures reflect private-pay, non-insured medical expenses, with Japanese consumption tax included.
| MSC Therapy Plan | Cost (Tax Included) |
| Light 100million×3sessions | ¥6,050,000 |
| Standard 150million×3sessions | ¥7,920,000 |
| Premium 200million×3sessions +Bonus | ¥9,900,000 |
Additional administration (MSC Therapy): ¥1,650,000 (tax included) per session
Frequently Asked Questions regarding IV Therapy
Direct answers to clinical inquiries. Evidence-based. Unembellished.
Rather than administering unapproved compounds or basic vitamins, IV therapy at Blu CLINIC is exclusively utilized as a systemic delivery method for cultured autologous Mesenchymal Stem Cells (MSCs). It is intended to support the body’s natural repair processes.
Primary downsides include the substantial financial investment and the multi-week culture period requiring extended stay or return travel. Physical risks include harvest site discomfort, as well as potential transient fever or allergic reactions during or shortly after the IV drip.
For our MSC intravenous protocols, cultured therapies range from ¥6,050,000 to ¥9,900,000, depending on cell volume and administration frequency. These figures are strictly out-of-pocket.
Administration is strictly contingent upon comprehensive preliminary blood testing conducted at our clinic upon arrival and physician evaluation. Individuals with active systemic infections, ongoing oncological treatments, severe blood coagulation disorders, or other critical contraindications identified during screening are not candidates for this protocol.
No. These regenerative protocols are entirely private-pay. They are not covered by Japanese public health insurance, nor do standard international private policies typically cover them.
Elite Medical Concierge and Support at Blu CLINIC
Flawless logistical support ensures your clinical focus. We provide complimentary transport from Kansai International Airport (KIX) to ease the physical burden of travel. Professional medical interpretation is included in the treatment package at no extra cost to ensure clear communication of complex medical information.
Autologous Adipose-Derived Stem Cell Therapy (MSC Therapy)
[Treatment Details] A treatment where stem cells derived from a small amount of adipose tissue and blood collected from the patient’s abdomen are cultured at an affiliated domestic cell processing facility (CPC), then administered via IV drip or injection.
[Standard Treatment Period & Sessions] Cell culturing takes approximately 3–4 weeks, and administration consists of 3 sessions in total per course.
[Standard Cost] ¥6,050,000 – ¥9,900,000 per course (Tax included) / Private-pay (Not covered by public health insurance). (*Additional administration: ¥1,650,000 per session.)
*Note: Counseling is free of charge, and required preliminary blood testing upon arrival as well as medical interpreter services are included in the treatment package at no extra cost.
[Risks & Side Effects] Pain, swelling, redness, and bruising at the collection or injection sites, transient fever, allergic reactions, and in rare cases, infection or breathing difficulties.
[Notes on Unapproved Products]
(i) This treatment uses regenerative medicine products that have not received approval under Japan’s Pharmaceuticals and Medical Devices (PMD) Act.
(ii) The cells used in this treatment are cultured and processed at an affiliated domestic cell processing facility (CPC) under the physician’s medical judgment, in accordance with Japan’s Act on the Safety of Regenerative Medicine. No personal importation of drugs is involved.
(iii) There are no other domestically approved drugs or medical devices with the same composition or performance.
(iv) Information regarding safety in foreign countries: This treatment has not been widely approved in major Western countries. There is a possibility that severe risks or side effects have not yet been fully identified.
(v) In the unlikely event of a severe side effect, this treatment is not covered by Japan’s Relief System for Sufferers from Adverse Drug Reactions or the Relief System for Infections from Biological Products.
Fibroblast Therapy
[Treatment Details] A treatment where fibroblasts extracted from skin tissue collected from behind the patient’s ear are cultured at a specialized cell processing facility (CPC), then transplanted directly into the dermal layer of areas where wrinkles and sagging are a concern.
[Standard Treatment Period & Sessions] Cell culturing takes approximately 3–5 weeks, and administration consists of 2 to 4 sessions in total, typically every 2 weeks.
[Standard Cost] ¥1,650,000 – ¥4,840,000 per course (Tax included) / Private-pay (Not covered by public health insurance).
*Note: Counseling is free of charge, and required preliminary blood testing upon arrival as well as medical interpreter services are included in the treatment package at no extra cost.
[Risks & Side Effects] Pain, swelling, redness, and bruising at the collection or injection sites, temporary unevenness, and in rare cases, infection.
[Notes on Unapproved Products]
(i) This treatment uses regenerative medicine products that have not received approval under Japan’s Pharmaceuticals and Medical Devices (PMD) Act.
(ii) The cells used in this treatment are cultured and processed at an affiliated domestic cell processing facility (CPC) under the physician’s medical judgment, in accordance with Japan’s Act on the Safety of Regenerative Medicine. No personal importation of drugs is involved.
(iii) There are no other domestically approved drugs or medical devices with the same composition or performance.
(iv) Information regarding safety in foreign countries: This treatment has not been widely approved in major Western countries. There is a possibility that severe risks or side effects have not yet been fully identified.
(v) In the unlikely event of a severe side effect, this treatment is not covered by Japan’s Relief System for Sufferers from Adverse Drug Reactions or the Relief System for Infections from Biological Products.
For more details on costs and treatment options,
please join our local information session.
